AERPIO PHARMACEUTICALS INC

Q2 2021 13F Holders

CUSIP
00810B105
Type
Equity
Class
COM
Num filings
44
Total reported value, excl. options
$51.0 M
Manager Report Date Value ($000) Shares Option Type